Clinical Trials at START Midwest

As of July 2026, 61 paid clinical trials are recruiting at START Midwest, located at 750 FRONT AVE NW STE 311, GRAND RAPIDS, MI 49504-4400, phone (616) 459-8971 in Grand Rapids, Michigan. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 16, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

61 clinical trials at START Midwest

·Clear filters·↓ Download CSV

A Study of MGC026 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

7 locations incl. Los Angeles

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06242470·Phase 1·Recruiting

Apply to this trial

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

for Metastatic Castration-resistant Prostate Neoplasms

Drug: Pasritamig

7 locations incl. Sarasota

Sponsor: Janssen Research & Development, LLC

Sex: Male·Age: 18+

Code: NCT05818683·Phase 1·Recruiting

Apply to this trial

First-in-human, Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) Alone or in Combination With Pembrolizumab in Stage II-- III Triple Negative Breast Cancer Following Standard Therapy ( VITAL-TNBC )

for Triple Negative Breast Cancer (TNBC)

2 locations incl. Grand Rapids

Sponsor: Immunomic Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT07652242·Phase 1·Recruiting·Listed Jun 17, 2026

Apply to this trial

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

for Hematologic Neoplasms

3 locations incl. Indianapolis

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07572006·Phase 1·Recruiting

Apply to this trial

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

for Gastrointestinal Cancers

2 locations incl. Grand Rapids

Sponsor: Genmab

Sex: All·Age: 18+

Code: NCT07539311·Phase 2·Recruiting

Apply to this trial

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

11 locations incl. Birmingham

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07488676·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

for Multiple Myeloma

10 locations incl. Scottsdale

Sponsor: C4 Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07284758·Phase 2·Recruiting

Apply to this trial

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

for Multiple Myeloma

5 locations incl. Duarte

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07409246·Phase 1·Recruiting

Apply to this trial

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

for Non-small Cell Lung Cancer (NSCLC)

9 locations incl. New Haven

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07349537·Phase 1·Recruiting

Apply to this trial

An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors

for Advanced Malignant Solid Tumor

1 location in Grand Rapids

Sponsor: Repertoire Immune Medicines

Sex: All·Age: 18+

Code: NCT07293754·Phase 1, Phase 2·Recruiting

Apply to this trial

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: Pumitamig

4 locations incl. New Haven

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07079631·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for Platinum-resistant Ovarian Cancer

7 locations incl. Los Angeles

Sponsor: MacroGenics

Sex: Female·Age: 18+

Code: NCT06730347·Phase 2·Recruiting

Apply to this trial

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

7 locations incl. Duarte

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT06969430·Phase 1, Phase 2·Recruiting

Apply to this trial

ARC101 in Advanced Solid Tumors

for Advanced Solid Tumor

3 locations incl. Boston

Sponsor: Third Arc Bio

Sex: All·Age: 18+

Code: NCT06672185·Phase 1·Recruiting

Apply to this trial

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

4 locations incl. Los Angeles

Sponsor: Tanabe Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT06943521·Phase 1, Phase 2·Recruiting

Apply to this trial

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

4 locations incl. Los Angeles

Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05985655·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

for Advanced Solid Tumors

Drug: Calderasib

6 locations incl. Tampa

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05067283·Phase 1·Recruiting

Apply to this trial

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

for Solid Tumors

8 locations incl. Duarte

Sponsor: Adcentrx Therapeutics

Sex: All·Age: 18+

Code: NCT06710379·Phase 1·Recruiting

Apply to this trial

Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

for Solid Tumor

4 locations incl. Scottsdale

Sponsor: Qualigen Theraputics, Inc.

Sex: All·Age: 18+

Code: NCT06086522·Phase 1·Recruiting

Apply to this trial

DBC-664 in Adult Patients With Solid Tumors Associated

for Malignant Germ Cell Tumor

3 locations incl. Grand Rapids

Sponsor: Duboce Biopharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07705035·Phase 1·Recruiting·Listed Jul 15, 2026

Apply to this trial

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for Colorectal Cancer

5 locations incl. Los Angeles

Sponsor: Verastem, Inc.

Sex: All·Age: 18+

Code: NCT07659795·Phase 2·Recruiting·Listed Jun 22, 2026

Apply to this trial